BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yadav BS, Chanana P, Jhamb S. Biomarkers in triple negative breast cancer: A review. World J Clin Oncol 2015; 6(6): 252-263 [PMID: 26677438 DOI: 10.5306/wjco.v6.i6.252]
URL: https://www.wjgnet.com/1007-9327/full/v6/i6/252.htm
Number Citing Articles
1
Alexus Acton, William J. Placzek. Myeloid Cell Leukemia 1 Small Molecule Inhibitor S63845 Synergizes with Cisplatin in Triple-Negative Breast CancerCancers 2023; 15(18): 4481 doi: 10.3390/cancers15184481
2
Richard D. A. Wilkinson, Roberta E. Burden, Sara H. McDowell, Darragh G. McArt, Stephen McQuaid, Victoria Bingham, Rich Williams, Órla T. Cox, Rosemary O’Connor, Nuala McCabe, Richard D. Kennedy, Niamh E. Buckley, Christopher J. Scott. A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast CancerJournal of Oncology 2019; 2019: 1 doi: 10.1155/2019/3980273
3
Soo-Yeon Hwang, Seojeong Park, Youngjoo Kwon. Recent therapeutic trends and promising targets in triple negative breast cancerPharmacology & Therapeutics 2019; 199: 30 doi: 10.1016/j.pharmthera.2019.02.006
4
Ramya Ambur Sankaranarayanan, Alexandru Florea, Susanne Allekotte, Andreas T. J. Vogg, Jochen Maurer, Laura Schäfer, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Agnieszka Morgenroth, Felix M. Mottaghy. PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancerEJNMMI Research 2022; 12(1) doi: 10.1186/s13550-022-00932-9
5
R. M. Paltuev. Biological rationale for patient-specific treatment of breast cancer. Analysis of new data for breast cancerTumors of female reproductive system 2020; 15(4): 30 doi: 10.17650/1994-4098-2019-15-4-30-49
6
Cláudia Lopes, Paulina Piairo, Alexandre Chícharo, Sara Abalde-Cela, Liliana R. Pires, Patrícia Corredeira, Patrícia Alves, Laura Muinelo-Romay, Luís Costa, Lorena Diéguez. HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic DeviceCancers 2021; 13(17): 4446 doi: 10.3390/cancers13174446
7
Bowen Li, Jianwu Tian, Xin Xie, Fu Zhang, Chongzhi Wu, Yi Shan, Guobin Qi, Wentao Song, Yuan Ping, Bin Liu. Overcoming ROS Resistance of Photodynamic Therapy with Self‐Assembled Nano‐Prodrugs for Efficient Triple‐Negative Breast CancerAdvanced Functional Materials 2024; 34(4) doi: 10.1002/adfm.202309524
8
Mansi Shah, Ryan Cardenas, Belinda Wang, Jenny Persson, Nigel P. Mongan, Anna Grabowska, Cinzia Allegrucci. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cellsMolecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0605-z
9
Shahensha Shaik, Ha’reanna Campbell, Christopher Williams. NURR1 Is Differentially Expressed in Breast Cancer According to Patient Racial Identity and Tumor SubtypeBioMedInformatics 2022; 2(4): 680 doi: 10.3390/biomedinformatics2040045
10
Eman F. Abdelhaleem, Mohammed K. Abdelhameid, Asmaa E. Kassab, Manal M. Kandeel. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7European Journal of Medicinal Chemistry 2018; 143: 1807 doi: 10.1016/j.ejmech.2017.10.075
11
Fabiola Giudici, Elisabetta Petracci, Oriana Nanni, Cristina Bottin, Maurizio Pinamonti, Fabrizio Zanconati, Bruna Scaggiante, Aamir Ahmad. Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosisPLOS ONE 2019; 14(6): e0218030 doi: 10.1371/journal.pone.0218030
12
Ruihao Li, Xiaochun Hu, Fangjian Shang, Wenjing Wu, Haijun Zhang, Yixuan Wang, Jiawei Pan, Shuo Shi, Chunyan Dong. Treatment of triple negative breast cancer by near infrared light triggered mild-temperature photothermal therapy combined with oxygen-independent cytotoxic free radicalsActa Biomaterialia 2022; 148: 218 doi: 10.1016/j.actbio.2022.06.011
13
Yu Zhou, Yingqi Che, Zhongze Fu, Henan Zhang, Huiyu Wu. Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and ImmunotherapyFrontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.902378
14
Jessica Iorio, Icro Meattini, Simonetta Bianchi, Marco Bernini, Virginia Maragna, Luca Dominici, Donato Casella, Vania Vezzosi, Lorenzo Orzalesi, Jacopo Nori, Lorenzo Livi, Annarosa Arcangeli, Elena Lastraioli. hERG1 channel expression associates with molecular subtypes and prognosis in breast cancerCancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0592-1
15
Hamsa D, Praveen Kumar K, Shanmughavel P, Poornima A, Sumathi S. Screening of key modulatory genes by Degalactotigonin in Triple Negative Breast Cancer cells – An in silico approachMeta Gene 2020; 26: 100799 doi: 10.1016/j.mgene.2020.100799
16
Elizabeth A. Wilson, Nahid Sultana, Khyati N. Shah, Howard L. Elford, Jesika S. Faridi. Molecular Targeting of RRM2, NF-κB, and Mutant TP53 for the Treatment of Triple-Negative Breast CancerMolecular Cancer Therapeutics 2021; 20(4): 655 doi: 10.1158/1535-7163.MCT-20-0373
17
Chun-Yu Liu, Tzu-Ting Huang, Pei-Yi Chu, Chun-Teng Huang, Chia-Han Lee, Wan-Lun Wang, Ka-Yi Lau, Wen-Chun Tsai, Tzu-I Chao, Jung-Chen Su, Ming-Huang Chen, Chung-Wai Shiau, Ling-Ming Tseng, Kuen-Feng Chen. The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cellsExperimental & Molecular Medicine 2017; 49(8): e366 doi: 10.1038/emm.2017.114
18
Shuang Hao, Zhi-Xian He, Ke-Da Yu, Wen-Tao Yang, Zhi-Min Shao. New insights into the prognostic value of Ki-67 labeling index in patients with triple-negative breast cancerOncotarget 2016; 7(17): 24824 doi: 10.18632/oncotarget.8531
19
Ozge Saatci, Aysegul Kaymak, Umar Raza, Pelin G. Ersan, Ozge Akbulut, Carolyn E. Banister, Vitali Sikirzhytski, Unal Metin Tokat, Gamze Aykut, Suhail A. Ansari, Hayriye Tatli Dogan, Mehmet Dogan, Pouria Jandaghi, Aynur Isik, Fatma Gundogdu, Kemal Kosemehmetoglu, Omer Dizdar, Sercan Aksoy, Aytekin Akyol, Aysegul Uner, Phillip J. Buckhaults, Yasser Riazalhosseini, Ozgur Sahin. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancerNature Communications 2020; 11(1) doi: 10.1038/s41467-020-16199-4
20
Janis Stiefel, Michael Baßler, Jörn Wittek, Christian Freese. Automated Immunomagnetic Enrichment and Optomicrofluidic Detection to Isolate Breast Cancer Cells: A Proof-of-Concept towards PoC Therapeutic Decision-MakingMagnetochemistry 2022; 8(9): 99 doi: 10.3390/magnetochemistry8090099
21
Mellisa Renteria, Ofek Belkin, David Jang, Justin Aickareth, Muaz Bhalli, Jun Zhang. CmPn signaling networks in the tumorigenesis of breast cancerFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1013892
22
Teng Pan, Tingting Mao, Haiyan Yang, Haiyu Wang, Yadong Wang. Silencing of TGIF sensitizes MDA‑MB‑231 human breast cancer cells to cisplatin‑induced apoptosisExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.5780
23
Elisa Roda, Fabrizio De Luca, Carmine Di Iorio, Daniela Ratto, Stella Siciliani, Beatrice Ferrari, Filippo Cobelli, Giuseppina Borsci, Erica Cecilia Priori, Silvia Chinosi, Andrea Ronchi, Renato Franco, Raffaele Di Francia, Massimiliano Berretta, Carlo Alessandro Locatelli, Andrej Gregori, Elena Savino, Maria Grazia Bottone, Paola Rossi. Novel Medicinal Mushroom Blend as a Promising Supplement in Integrative Oncology: A Multi-Tiered Study using 4T1 Triple-Negative Mouse Breast Cancer ModelInternational Journal of Molecular Sciences 2020; 21(10): 3479 doi: 10.3390/ijms21103479
24
Kamali Chakkaravarthi, Rajashree Ramesh, Thirunavukkarasu Palaniyandi, Gomathy Baskar, Sandhiya Viswanathan, Mugip Rahaman Abdul Wahab, Hemapreethi Surendran, Maddaly Ravi, Asha Sivaji. Prospectives of mirna gene signaling pathway in triple-negative breast cancerPathology - Research and Practice 2023; 248: 154658 doi: 10.1016/j.prp.2023.154658
25
Natalia Gurvits, Eliisa Löyttyniemi, Marjukka Nykänen, Teijo Kuopio, Pauliina Kronqvist, Kati Talvinen. Separase is a marker for prognosis and mitotic activity in breast cancerBritish Journal of Cancer 2017; 117(9): 1383 doi: 10.1038/bjc.2017.301
26
Junping Liu, Wei Zhang, Wanxia Cai, Yumei Chen, Xiaozhong Cai, Donge Tang, Min Tang, Yong Dai. Multi-Omics Analyses Revealed GOLT1B as a Potential Prognostic Gene in Breast Cancer Probably Regulating the Immune MicroenvironmentFrontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.805273
27
Muhseena N. Katheeja, Shankar Prasad Das, Ranajit Das, Suparna Laha. BRCA1 interactors, RAD50 and BRIP1, as prognostic markers for triple-negative breast cancer severityFrontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1035052
28
Qiuhong Wang, Sheng Gao, Haibo Li, Mingming Lv, Cheng Lu. Long noncoding RNAs (lncRNAs) in triple negative breast cancerJournal of Cellular Physiology 2017; 232(12): 3226 doi: 10.1002/jcp.25830
29
Yaming Li, Ning Zhang, Hanwen Zhang, Qifeng Yang. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinomaJournal of Clinical Pathology 2019; 72(6): 418 doi: 10.1136/jclinpath-2018-205544
30
Shuxun Shi, Cong Xu, Xiaonan Fang, Yonghuan Zhang, Hua Li, Wujun Wen, Guiwen Yang. Expression profile of Toll‑like receptors in human breast cancerMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10853
31
Humaira Khan, Muhammad Raza Shah, Jiri Barek, Muhammad Imran Malik. Cancer biomarkers and their biosensors: A comprehensive reviewTrAC Trends in Analytical Chemistry 2023; 158: 116813 doi: 10.1016/j.trac.2022.116813
32
Elisa Roda, Fabrizio De Luca, Carlo Alessandro Locatelli, Daniela Ratto, Carmine Di Iorio, Elena Savino, Maria Grazia Bottone, Paola Rossi. From a Medicinal Mushroom Blend a Direct Anticancer Effect on Triple-Negative Breast Cancer: A Preclinical Study on Lung MetastasesMolecules 2020; 25(22): 5400 doi: 10.3390/molecules25225400
33
Marissa Howard, James Erickson, Zachary Cuba, Shawn Kim, Weidong Zhou, Purva Gade, Rachel Carter, Kelsey Mitchell, Heather Branscome, Daivik Siddhi, Fatimah Alanazi, Yuriy Kim, Robyn P. Araujo, Amanda Haymond, Alessandra Luchini, Fatah Kashanchi, Lance A. Liotta. A secretory form of Parkin‐independent mitophagy contributes to the repertoire of extracellular vesicles released into the tumour interstitial fluid in vivoJournal of Extracellular Vesicles 2022; 11(7) doi: 10.1002/jev2.12244
34
G.I. Uscanga-Perales, S.K. Santuario-Facio, R. Ortiz-López. Triple negative breast cancer: Deciphering the biology and heterogeneityMedicina Universitaria 2016; 18(71): 105 doi: 10.1016/j.rmu.2016.05.007
35
Guangcun Cheng, Xuemei Fan, Mingang Hao, Jinglong Wang, Xiaoming Zhou, Xueqing Sun. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancerMolecular Cancer 2016; 15(1) doi: 10.1186/s12943-016-0515-5
36
Tamás Mezei, Melinda Hajdu, Gábor Czigléczki, Gábor Lotz, Judit Kocsis, Janina Kulka, Anna Horváth. Sterile, abscess-like cerebral lesion during trastuzumab therapy after HER2 status switch in a triple negative breast cancer patient: a case report and literature reviewBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07114-7
37
Bruno Gil, Meysam Keshavarz, Dominic Wales, Ara Darzi, Eric Yeatman. Orthogonal Surface‐Enhanced Raman Scattering/Field‐Effect Transistor Detection of Breast and Colorectal Cancer‐Derived Exosomes using Graphene as a Tag‐Free Diagnostic TemplateAdvanced NanoBiomed Research 2023; 3(11) doi: 10.1002/anbr.202300055
38
Yuxin Xie, Qiheng Gou, Qianqian Wang, Xiaorong Zhong, Hong Zheng. The role of BRCA status on prognosis in patients with triple-negative breast cancerOncotarget 2017; 8(50): 87151 doi: 10.18632/oncotarget.19895
39
Jessica Catarine Frutuoso do Nascimento, Eduardo Isidoro Carneiro Beltrão, Cíntia Renata Costa Rocha. High FUT3 expression is a marker of lower overall survival of breast cancer patientsGlycoconjugate Journal 2020; 37(2): 263 doi: 10.1007/s10719-020-09914-2
40
Rui Hong, Hongyu Sun, Dujuan Li, Weihuang Yang, Kai Fan, Chaoran Liu, Linxi Dong, Gaofeng Wang. A Review of Biosensors for Detecting Tumor Markers in Breast CancerLife 2022; 12(3): 342 doi: 10.3390/life12030342
41
Chen-Yun Wang, Cing-Hong Wang, Ru-Tsun Mai, Ting-Wen Chen, Chia-Wei Li, Chi-Hong Chao. Mutant p53-microRNA-200c-ZEB2-Axis-Induced CPT1C Elevation Contributes to Metabolic Reprogramming and Tumor Progression in Basal-Like Breast CancersFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.940402
42
Abhilasha Sinha, Bibbin T. Paul, Lisa M. Sullivan, Hillary Sims, Ahmed El Bastawisy, Hend F. Yousef, Abdel-Rahman N. Zekri, Abeer A. Bahnassy, Wael M. ElShamy. BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesionsOncotarget 2017; 8(6): 10114 doi: 10.18632/oncotarget.14357
43
Andrea Angius, Paolo Cossu-Rocca, Caterina Arru, Maria Rosaria Muroni, Vincenzo Rallo, Ciriaco Carru, Paolo Uva, Giovanna Pira, Sandra Orrù, Maria Rosaria De Miglio. Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like PhenotypeCancers 2020; 12(11): 3298 doi: 10.3390/cancers12113298
44
Longquan Lou, Ziyi Yu, Yue Wang, Shui Wang, Yi Zhao. c‐Src inhibitor selectively inhibits triple‐negative breast cancer overexpressed Vimentin in vitro and in vivoCancer Science 2018; 109(5): 1648 doi: 10.1111/cas.13572
45
Eunah Cho, Yeo-Jung Kwon, Dong-Jin Ye, Hyoung-Seok Baek, Tae-Uk Kwon, Hyung-Kyoon Choi, Young-Jin Chun. G0/G1 Switch 2 Induces Cell Survival and Metastasis through Integrin-Mediated Signal Transduction in Human Invasive Breast Cancer CellsBiomolecules & Therapeutics 2019; 27(6): 591 doi: 10.4062/biomolther.2019.063
46
Insaf Fkih M’hamed, Maud Privat, Mounir Trimeche, Frédérique Penault-Llorca, Yves-Jean Bignon, Abderraouf Kenani. miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential BiomarkersPathology & Oncology Research 2017; 23(4): 815 doi: 10.1007/s12253-017-0188-4
47
Su-Hyeong Kim, Eun-Ryeong Hahm, Julie A. Arlotti, Suman K. Samanta, Michelle B. Moura, Stephen H. Thorne, Yongli Shuai, Carolyn J. Anderson, Alexander G. White, Anna Lokshin, Joomin Lee, Shivendra V. Singh. Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdownBreast Cancer Research and Treatment 2016; 157(1): 41 doi: 10.1007/s10549-016-3795-y
48
Nilofer Shaikh, Sanket Bapat, Muthukumarasamy Karthikeyan, Renu Vyas. A Review on Computational Analysis of Big Data in Breast Cancer for Predicting Potential BiomarkersCurrent Topics in Medicinal Chemistry 2022; 22(21): 1793 doi: 10.2174/1568026622666220907121942
49
Daniela Massihnia, Alessandro Perez, Viviana Bazan, Giuseppe Bronte, Marta Castiglia, Daniele Fanale, Nadia Barraco, Antonina Cangemi, Florinda Di Piazza, Valentina Calò, Sergio Rizzo, Giuseppe Cicero, Gianni Pantuso, Antonio Russo. A headlight on liquid biopsies: a challenging tool for breast cancer managementTumor Biology 2016; 37(4): 4263 doi: 10.1007/s13277-016-4856-x
50
Eliana Noelia Alonso, María Julia Ferronato, María Eugenia Fermento, Norberto Ariel Gandini, Alejandro López Romero, Josefina Alejandra Guevara, María Marta Facchinetti, Alejandro Carlos Curino. Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cellsOncotarget 2018; 9(34): 23396 doi: 10.18632/oncotarget.25174
51
Katheeja Muhseena N, Sooraj Mathukkada, Shankar Prasad Das, Suparna Laha. The repair gene <em>BACH1</em> - a potential oncogeneOncology Reviews 2021; 15(1) doi: 10.4081/oncol.2021.519
52
Abhishek Kanugo, Rupesh K. Gautam, Mohammad Amjad Kamal. Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC)Current Pharmaceutical Biotechnology 2022; 23(13): 1581 doi: 10.2174/1389201023666211230113658
53
Charu Kothari, Mazid Abiodoun Osseni, Lynda Agbo, Geneviève Ouellette, Maxime Déraspe, François Laviolette, Jacques Corbeil, Jean-Philippe Lambert, Caroline Diorio, Francine Durocher. Machine learning analysis identifies genes differentiating triple negative breast cancersScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-67525-1
54
Pei-Jou Chua, Suet-Hui Ow, Cheng-Teng Ng, Wan-Hong Huang, Jie-Ting Low, Puay Hoon Tan, Michael W.Y. Chan, Boon-Huat Bay. Peroxiredoxin 3 regulates breast cancer progression via ERK-mediated MMP-1 expressionCancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03248-x
55
Ashutosh Gupta, Kumar Nishchaya, Moumita Saha, Gaurisha Alias Resha Ramnath Naik, Sarika Yadav, Shreya Srivastava, Amrita Arup Roy, Sudheer Moorkoth, Srinivas Mutalik, Namdev Dhas. Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancerJournal of Drug Delivery Science and Technology 2024; 93: 105401 doi: 10.1016/j.jddst.2024.105401
56
Nihad Al-Othman, Mamoun Ahram, Moath Alqaraleh. Role of androgen and microRNA in triple-negative breast cancerBreast Disease 2020; 39(1): 15 doi: 10.3233/BD-190416
57
Bayan Zoatier, Metin Yildirim, Mehmet Abdullah Alagoz, Derya Yetkin, Burcin Turkmenoglu, Serdar Burmaoglu, Oztekin Algul. N-(benzazol-2-yl)-2-substituted phenylacetamide derivatives: Design, synthesis and biological evaluation against MCF7 breast cancer cell lineJournal of Molecular Structure 2023; 1285: 135513 doi: 10.1016/j.molstruc.2023.135513
58
Michaela Aubele, Manfred Schmitt, Rudolf Napieralski, Stefan Paepke, Johannes Ettl, Magdalena Absmaier, Viktor Magdolen, John Martens, John A. Foekens, Olaf G. Wilhelm, Marion Kiechle. The Predictive Value ofPITX2DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and ChallengesDisease Markers 2017; 2017: 1 doi: 10.1155/2017/4934608
59
I. Roxanis, R. Colling, C. Kartsonaki, A. R. Green, E A. Rakha. The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysisBreast Cancer Research 2018; 20(1) doi: 10.1186/s13058-018-0934-x
60
Hyejin Ko, Jong Lee, Hyun Kim, Taewoo Kim, Young Han, Young-Ger Suh, Jaemoo Chun, Yeong Kim, Kwang Ahn. Novel Galiellalactone Analogues Can Target STAT3 Phosphorylation and Cause Apoptosis in Triple-Negative Breast CancerBiomolecules 2019; 9(5): 170 doi: 10.3390/biom9050170
61
A-In Kim, Ji Hoon Oh, Je-Yoel Cho. QSOX2 Upregulated in triple-negative breast cancer exacerbates patient prognosis by stabilizing integrin β1Heliyon 2024; 10(6): e27148 doi: 10.1016/j.heliyon.2024.e27148
62
Monica J. Engstrøm, Marit Valla, Anna M. Bofin. Basal markers and prognosis in luminal breast cancerBreast Cancer Research and Treatment 2017; 163(2): 207 doi: 10.1007/s10549-017-4182-z
63
Siliang Xue, Lang He, Xiao Zhang, Jin Zhou, Fanghua Li, Xiaoshan Wang. Expression of Jagged1/Notch3 Signaling Pathway and their Relationship with the Tumor Angiogenesis in TNBCArchives of Medical Research 2017; 48(2): 169 doi: 10.1016/j.arcmed.2017.03.014
64
Feng Yang, Michaela Aubele, Axel Walch, Eva Gross, Rudolf Napieralski, Shuo Zhao, Nancy Ahmed, Marion Kiechle, Ute Reuning, Julia Dorn, Fred Sweep, Viktor Magdolen, Manfred Schmitt. Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancerBiological Chemistry 2017; 398(10): 1151 doi: 10.1515/hsz-2017-0122
65
Miseon Lee, In Ah Park, Sun-Hee Heo, Young-Ae Kim, Gyungyub Gong, Hee Jin Lee. Association between p53 Expression and Amount of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast CancerJournal of Pathology and Translational Medicine 2019; 53(3): 180 doi: 10.4132/jptm.2019.02.08
66
John J. Bassett, Alice H.L. Bong, Ellen K. Janke, Mélanie Robitaille, Sarah J. Roberts-Thomson, Amelia A. Peters, Gregory R. Monteith. Assessment of cytosolic free calcium changes during ceramide-induced cell death in MDA-MB-231 breast cancer cells expressing the calcium sensor GCaMP6mCell Calcium 2018; 72: 39 doi: 10.1016/j.ceca.2018.02.003
67
Yonglin Zhao, Xing Wei, Jia Li, Yan Diao, Changyou Shan, Weimiao Li, Shuqun Zhang, Fei Wu. High Level of GMFG Correlated to Poor Clinical Outcome and Promoted Cell Migration and Invasion through EMT Pathway in Triple-Negative Breast CancerGenes 2023; 14(6): 1157 doi: 10.3390/genes14061157
68
Xiaolu Yang, Tiantian Tang, Tao Zhou. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysisWorld Journal of Surgical Oncology 2023; 21(1) doi: 10.1186/s12957-023-03261-w
69
Touko Inao, Yuichi Iida, Tamami Moritani, Tamio Okimoto, Ryosuke Tanino, Hitoshi Kotani, Mamoru Harada. Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicinOncotarget 2018; 9(39): 25545 doi: 10.18632/oncotarget.25370
70
Guochen Zhang, Junlan Wang, Ruilin Zheng, Beibei Song, Li Huang, Yujiang Liu, Yating Hao, Xiangdong Bai. MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer CellsTechnology in Cancer Research & Treatment 2020; 19: 153303382092701 doi: 10.1177/1533033820927011
71
Xuan-Yu Mao, Jesus Perez-Losada, Mar Abad, Marta Rodríguez-González, Cesar A Rodríguez, Jian-Hua Mao, Hang Chang. iCEMIGE: Integration of CEll-morphometrics, MIcrobiome, and GEne biomarker signatures for risk stratification in breast cancersWorld Journal of Clinical Oncology 2022; 13(7): 616-629 doi: 10.5306/wjco.v13.i7.616
72
Pamungkas Satriyo, Oluwaseun Bamodu, Jia-Hong Chen, Teguh Aryandono, Sofia Haryana, Chi-Tai Yeh, Tsu-Yi Chao. Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast CancerJournal of Clinical Medicine 2019; 8(2): 148 doi: 10.3390/jcm8020148
73
Ishita Gupta, Rasha Sareyeldin, Israa Al-Hashimi, Hamda A. Al-Thawadi, Halema Al Farsi, Semir Vranic, Ala-Eddin Al Moustafa. Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to EthnicityCancers 2019; 11(3): 363 doi: 10.3390/cancers11030363
74
Halima Alsamri, Hussain El Hasasna, Yusra Al Dhaheri, Ali H. Eid, Samir Attoub, Rabah Iratni. Carnosol, a Natural Polyphenol, Inhibits Migration, Metastasis, and Tumor Growth of Breast Cancer via a ROS-Dependent Proteasome Degradation of STAT3Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00743
75
Bin Xiong, Xuefeng Lei, Lei Zhang, Jia Fu. The clinical significance and biological function of olfactomedin 4 in triple negative breast cancerBiomedicine & Pharmacotherapy 2017; 86: 67 doi: 10.1016/j.biopha.2016.11.081
76
Ishita Gupta, Balsam Rizeq, Semir Vranic, Ala-Eddin Al Moustafa, Halema Al Farsi. Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic TargetsInternational Journal of Molecular Sciences 2020; 21(18): 6750 doi: 10.3390/ijms21186750
77
Dana M. Zaher, Iman M. Talaat, Amal Hussein, Mahmood Y. Hachim, Hany A. Omar. Differential expression of pyruvate dehydrogenase E1A and its inactive phosphorylated form among breast cancer subtypesLife Sciences 2021; 284: 119885 doi: 10.1016/j.lfs.2021.119885
78
Anindita De, Sonam Patel, K. Gowthamarajan. Functional Smart Nanomaterials and Their Theranostics ApproachesSmart Nanomaterials Technology 2024; : 119 doi: 10.1007/978-981-99-6597-7_5
79
Binbin Tan, Ying Zhang, Tiantian Zhang, Jinsong He, Xueying Luo, Xiqing Bian, Jianlin Wu, Chang Zou, Yangzhi Wang, Li Fu. Identifying potential serum biomarkers of breast cancer through targeted free fatty acid profiles screening based on a GC–MS platformBiomedical Chromatography 2020; 34(10) doi: 10.1002/bmc.4922
80
Silvia Cecilia Pacheco-Velázquez, Juan Carlos Gallardo-Pérez, Daniel Díaz, Alhelí Adán-Ladrón de Guevara, Diana Xochiquetzal Robledo-Cadena, Emma Saavedra, Luz Ruiz-Godoy, Luis Roberto Jimenez-Hernández, Jesús Vargas-Barrón, José Luis Aguilar-Ponce, Sara Rodríguez-Enríquez. Heart myxoma develops oncogenic and metastatic phenotypeJournal of Cancer Research and Clinical Oncology 2019; 145(5): 1283 doi: 10.1007/s00432-019-02897-0
81
Elnaz Faghfuri, Mohsen Sagha, Amir Hossein Faghfouri. The Cytotoxicity Effect of Curcumin Loaded Folic Acid Conjugated-Nanoparticles on Breast Cancer Cells and Its Association with Inhibition of STAT3 PhosphorylationJournal of Cluster Science 2022; 33(5): 2037 doi: 10.1007/s10876-021-02125-1
82
Felipe C. M. Zoppino, Martin E. Guerrero-Gimenez, Gisela N. Castro, Daniel R. Ciocca. Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancerBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4621-1
83
Brianna J. McIntosh, Griffin G. Hartmann, Sean A. Yamada‐Hunter, Phillip Liu, Camille F. Williams, Julien Sage, Jennifer R. Cochran. An engineered interleukin‐11 decoy cytokine inhibits receptor signaling and proliferation in lung adenocarcinomaBioengineering & Translational Medicine 2023; 8(6) doi: 10.1002/btm2.10573
84
Fouzia Guestini, Katsuhiko Ono, Minoru Miyashita, Takanori Ishida, Noriaki Ohuchi, Saki Nakagawa, Hisashi Hirakawa, Kentaro Tamaki, Yasuyo Ohi, Yoshiaki Rai, Yasuaki Sagara, Hironobu Sasano, Keely May McNamara. Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapyBreast Cancer Research and Treatment 2019; 173(2): 275 doi: 10.1007/s10549-018-4985-6
85
Aysha Alneyadi, Zohra Nausheen Nizami, Hanan E. Aburawi, Soleiman Hisaindee, Muhammad Nawaz, Samir Attoub, Gaber Ramadan, Nehla Benhalilou, Mazoun Al Azzani, Yassine Elmahi, Aysha Almeqbali, Khalid Muhammed, Ali H. Eid, Ranjit Vijayan, Rabah Iratni. Synthesis of New Chromene Derivatives Targeting Triple-Negative Breast Cancer CellsCancers 2023; 15(10): 2682 doi: 10.3390/cancers15102682
86
Zhen Li, Jian Dong, Tianning Zou, Chengzhi Du, Siyuan Li, Ceshi Chen, Rong Liu, Kunhua Wang. Dexamethasone induces docetaxel and cisplatin resistance partially through up-regulating Krüppel-like factor 5 in triple-negative breast cancerOncotarget 2017; 8(7): 11555 doi: 10.18632/oncotarget.14135